Histone deacetylase pathway: an evolving therapeutic target in chronic obstructive pulmonary disease

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.10, Iss.2, 2006-04, pp. : 329-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment

By Barnes Peter J

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1111-1121

Informa Healthcare

Access to resources Recommend Favorite

Nitric Oxide Synthase (NOS) as Therapeutic Target for Asthma and Chronic Obstructive Pulmonary Disease

Current Drug Targets, Vol. 7, Iss. 6, 2006-06 ,pp. : 721-735

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix Metalloproteinase-9/Gelatinase B is a Putative Therapeutic Target of Chronic Obstructive Pulmonary Disease and Multiple Sclerosis

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 1, 2008-02 ,pp. : 34-46

Bentham Science Publishers

Access to resources Recommend Favorite

Indacaterol: In Chronic Obstructive Pulmonary Disease

By Moen Marit D.

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2269-2280

Adis International

Access to resources Recommend Favorite

Roflumilast: In Chronic Obstructive Pulmonary Disease

By Sanford Mark

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1615-1627

Adis International

Access to resources Recommend Favorite